<DOC>
	<DOCNO>NCT00243841</DOCNO>
	<brief_summary>The purpose study determine maximum tolerate dose limited fraction large dose radiation effort achieve biologically potent cancer therapy select patient primary hepatocellular carcinoma .</brief_summary>
	<brief_title>Dose Escalation Study Primary Hepatocellular Carcinoma</brief_title>
	<detailed_description>Despite recent advance early detection diagnosis , 30-40 % patient hepatocellular carcinoma may benefit radical therapy . Liver transplantation offer best chance cure . Surgical resection potentially curative option , majority patient candidate resection . This reflect usual comorbidity severe underlie liver disease either precludes surgery make surgical approach extremely dangerous .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Evaluation Surgery and/or Liver Transplant Team perform patient consider candidate either `` standard '' therapy target area ( upper abdomen ) Adequate liver function define : total bilirubin &lt; 3mg/dl , albumin &gt; 2.5 g/dl normal PT/PTT unless anticoagulant mild elevation liver enzymes acceptable ( must less three time upper limit normal ) Adequate renal function ( creatinine &lt; 1.8 mg/dl creatinine clearance ≥ 50 ml/min ) Adequate bone marrow reserve : ANC count ≥ 1500 mm3 Platelets ≥ 50,000/mm3 Hemoglobin &gt; 9 g/dL NOTE : Lab value must obtain within 2 week prior register protocol therapy . No history systemic lupus erythematous , rheumatoid arthritis , systemic sclerosis scleroderma No chemotherapy within 14 day radiotherapy ( chemotherapy may cause transient hepatitis hepatomegaly ) No subsequent chemotherapy plan within 2 week radiotherapy No active liver infection No acute Hepatitis . Definition active disease : Hepatitis A : Acute hepatitis determine presence AntiHAV IgM Hepatitis B : 1 . HBsAg ( HB surface Antigen ) : present patient acute chronic hepatitis 2 . HBV DNA present patient active viral replication amount great 100,000 copy 3 . HBeAg present wild type HBV infection suggest active replication 4 . AntiHBs : Antibody HBsAg appear HBV infection confers immunity 5 . AntiHBcIgM : Antibody HBcAg , fraction IgM , present acute infection often could detect period high viral replication chronic disease 6 . AntiHBcIgG : present chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>